The Enzyme-Linked Immunosorbent Assay Testing Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size for the enzyme-linked immunosorbent assay testing has seen a steadfast growth recently. The market is set to increase from $2.85 billion in 2024 to $3.04 billion in 2025, registering a compound annual growth rate (CAGR) of 6.7%.
The Enzyme-Linked Immunosorbent Assay Testing Global Market is projected to grow to $3.88 billion by 2029, with a compound annual growth rate (CAGR) of 6.3%.
Download Your Free Sample of the 2025 Enzyme-Linked Immunosorbent Assay Testing Market Report and Uncover Key Trends Now!The key drivers in the enzyme-linked immunosorbent assay testing market are:
• Rising demand for personalized medicine
• Growing geriatric population and emphasis on early disease detection
• Improved access to healthcare services and need for chronic disease monitoring
• Technological advancements and expanding application areas in healthcare industry
The enzyme-linked immunosorbent assay testingmarket covered in this report is segmented –
1) By Type: Direct Enzyme-Linked Immunosorbent Assay (ELISA), Sandwich Enzyme-Linked Immunosorbent Assay (ELISA), Indirect Enzyme-Linked Immunosorbent Assay (ELISA), Multiple And Portable Enzyme-Linked Immunosorbent Assay (ELISA), Competitive Enzyme-Linked Immunosorbent Assay (ELISA)
2) By Application: Immunology, Inflammation, Infectious Diseases, Cancer, Protein Quantitation, Other Applications
3) By End-User: Hospitals And Diagnostic Centers, Research Laboratories, Other End-Users
The key trends in the enzyme-linked immunosorbent assay testing market are:
• Point-of-care testing is an emerging demand trend in the market.
• Expansion of application areas is shaping the future of the market.
• High-throughput screening adoption is a significant future trend.
• Digital ELISA is an emerging trend in the market.
Major companies in the enzyme-linked immunosorbent assay testing market are:
• Thermo Fisher Scientific Inc.
• Danaher Corporation
• Merck KGaA
• Siemens Healthineers
• Becton Dickinson and Company
• Agilent Technologies Inc.
• PerkinElmer Inc.
• Bio-Rad Laboratories Inc.
• Tecan Group Ltd.
• GenScript Biotech Corporation
• Promega Corporation
• Abcam plc
• R&D Systems Inc.
• Sino Biological Inc.
• OriGene Technologies Inc.
• RayBiotech Inc.
• Santa Cruz Biotechnology Inc.
• AnaSpec Inc.
• Biomatik
• Arigo Biolaboratories Corp.
• MyBioSource Inc.
• Boster Biological Technology
• Eagle Biosciences Inc.
• Enzo Life Sciences Inc.
• StressMarq Biosciences Inc.
• XpressBio
North America was the largest region in the enzyme-linked immunosorbent assay testing market in 2024